{"id":44336,"date":"2022-05-25T15:01:40","date_gmt":"2022-05-25T13:01:40","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/"},"modified":"2022-05-25T15:01:40","modified_gmt":"2022-05-25T13:01:40","slug":"anthem-foundation-commits-13-million-to-substance-use-disorder-programs","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/","title":{"rendered":"Anthem Foundation Commits $13 Million to Substance Use Disorder Programs"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>The Foundation will invest up to $30 million over next three years to programs that <\/i><i>support the mental health and well-being of communities with an emphasis on substance use disorders<\/i>\n<\/p>\n<p>INDIANAPOLIS&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.anthemcorporateresponsibility.com%2Fcr%2Ffoundation&amp;esheet=52729533&amp;newsitemid=20220525005134&amp;lan=en-US&amp;anchor=Anthem+Foundation&amp;index=1&amp;md5=36bb8271164ae0b8cbaf8233360509af\" rel=\"nofollow noopener\" shape=\"rect\">Anthem Foundation<\/a>, which will become Elevance Health Foundation on June 28, 2022, today announces the commitment of $13 million in grants to promote equity in mental health, particularly for people with substance use disorders. Each program will focus on one of the following goals: prevention and early intervention of risk factors that lead to substance use disorders, improved access and quality of treatment to reduce morbidity and mortality of substance use disorders, and community support to promote lifelong recovery. These grants are part of up to $30 million the Foundation plans to invest over the next three years to make significant progress toward reducing substance use disorders and their health impacts.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220525005134\/en\/1465880\/5\/AnthemFoundation_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220525005134\/en\/1465880\/21\/AnthemFoundation_Logo.jpg\"><\/a><\/p>\n<p>\nFor more than 20 years, the Anthem Foundation has supported nonprofits across the country that share its mission to improve lives and communities. With one in five Americans experiencing some type of mental health condition every year, the Foundation has made substance use disorder a key area of focus along with maternal, food as medicine, and disaster relief. These four pillars make up the Anthem Foundation\u2019s overall commitment of up to $90 million over the next three years to improve critical health and health equity challenges in communities today.\n<\/p>\n<p>\n\u201cToday, 9.5 million adults in the U.S. report having both a substance use disorder and a mental illness, and substance use disorders alone affect over 20 million Americans aged 12 and over. These startling figures drive home our commitment to partnering with organizations who are delivering solutions on a local and national level,\u201d said Shantanu Agrawal, M.D., Chief Health Officer of Anthem. \u201cBy acknowledging the physical, behavioral, and social drivers of health as they relate to substance use disorders, the Anthem Foundation \u2013 along with its recently awarded grantees \u2013 is positioned to provide meaningful solutions in achieving better health and advancing health equity.\u201d\n<\/p>\n<p>\nFifteen organizations will receive $13 million over the next three years as the first round of substance use disorder grantees. Organizations include:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nShatterproof\n<\/li>\n<li>\nMental Health America\n<\/li>\n<li>\nEmergency Medicine Foundation\n<\/li>\n<li>\nFaces and Voices of Recover\n<\/li>\n<li>\nPrevention Action Alliance\n<\/li>\n<li>\nDuke University\n<\/li>\n<li>\nSignature Health, Inc.\n<\/li>\n<li>\nFletcher Group, Inc.\n<\/li>\n<li>\nYouth First, Inc.\n<\/li>\n<li>\nStar House Foundation\n<\/li>\n<li>\nChris Atwood Foundation, Inc.\n<\/li>\n<li>\nYoung People in Recovery\n<\/li>\n<li>\nYWCA Northeast Indiana, Inc.\n<\/li>\n<li>\n3Trect, Inc. dba My Recovery Day\n<\/li>\n<li>\n24\/7 Gateway LLC\u00a0\n<\/li>\n<\/ul>\n<p>\nEach grant program will focus on at least one of the following themes: youth prevention and early intervention; access to care (e.g., reducing stigma among providers serving socially vulnerable populations, emergency room department enhanced education, etc.); and quality of treatment (e.g., supporting quality recovery housing, etc.). Collectively, these grants have the potential to reach 42 million Americans.\n<\/p>\n<p>\nThe Foundation\u2019s efforts in its four key focus areas will help the organization continue to foster its longstanding and deep presence in local communities while strategically aligning with Anthem\u2019s focus on community health and becoming a lifetime, trusted health partner.\n<\/p>\n<p>\nFor more information about the Anthem Foundation and future RFPs, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fanthem.foundation%2Ffor-grantseekers&amp;esheet=52729533&amp;newsitemid=20220525005134&amp;lan=en-US&amp;anchor=anthem.foundation%2Ffor-grantseekers&amp;index=2&amp;md5=4cbe5a1f316fea61b0eff760e83757ae\" rel=\"nofollow noopener\" shape=\"rect\">anthem.foundation\/for-grantseekers<\/a>.\n<\/p>\n<p>\n<b>ABOUT ANTHEM FOUNDATION<br \/>\n<br \/><\/b>The Anthem Foundation, which will become Elevance Health Foundation on June 28, 2022, works to address health equity by focusing on improving the health of the socially vulnerable through strategic partnerships and programs in our communities with an emphasis on maternal child health; mental health; and food as medicine. The Foundation also coordinates the company\u2019s year-round Dollars for Dollars program which provides a 100 percent match of associates\u2019 donations, as well as its Volunteer Time Off and Dollars for Doers community service programs. To learn more about the Anthem Foundation, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.anthem.foundation&amp;esheet=52729533&amp;newsitemid=20220525005134&amp;lan=en-US&amp;anchor=www.anthem.foundation&amp;index=3&amp;md5=d374b8a89c54618615bb7593056b0004\" rel=\"nofollow noopener\" shape=\"rect\">www.anthem.foundation<\/a> and its blog at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fmedium.com%2Fanthemfoundation&amp;esheet=52729533&amp;newsitemid=20220525005134&amp;lan=en-US&amp;anchor=https%3A%2F%2Fmedium.com%2Fanthemfoundation&amp;index=4&amp;md5=25aac3ecb2b488b19978ba5fcd113708\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/medium.com\/anthemfoundation<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nVanessa Stepanek<br \/>\n<br \/>Anthem Foundation<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#97;&#x69;&#x6c;&#116;&#111;&#x3a;&#x56;&#97;&#110;&#x65;&#x73;&#115;&#97;&#x2e;&#x73;&#116;&#101;&#x70;&#x61;&#110;&#101;&#x6b;&#x40;&#97;&#110;&#x74;&#x68;&#101;&#109;&#x2e;&#x63;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x56;&#x61;&#x6e;&#x65;&#x73;&#x73;&#x61;&#x2e;&#x53;&#x74;&#x65;&#x70;&#x61;&#x6e;&#x65;&#x6b;&#x40;&#x61;&#x6e;&#x74;&#x68;&#x65;&#109;&#46;&#99;&#111;&#109;<\/a><br \/>765-412-2803\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The Foundation will invest up to $30 million over next three years to programs that support the mental health and well-being of communities with an emphasis on substance use disorders INDIANAPOLIS&#8211;(BUSINESS WIRE)&#8211;The Anthem Foundation, which will become Elevance Health Foundation on June 28, 2022, today announces the commitment of $13 million in grants to promote &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44336","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anthem Foundation Commits $13 Million to Substance Use Disorder Programs - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anthem Foundation Commits $13 Million to Substance Use Disorder Programs - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The Foundation will invest up to $30 million over next three years to programs that support the mental health and well-being of communities with an emphasis on substance use disorders INDIANAPOLIS&#8211;(BUSINESS WIRE)&#8211;The Anthem Foundation, which will become Elevance Health Foundation on June 28, 2022, today announces the commitment of $13 million in grants to promote ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-25T13:01:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220525005134\/en\/1465880\/21\/AnthemFoundation_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Anthem Foundation Commits $13 Million to Substance Use Disorder Programs\",\"datePublished\":\"2022-05-25T13:01:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\\\/\"},\"wordCount\":638,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220525005134\\\/en\\\/1465880\\\/21\\\/AnthemFoundation_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\\\/\",\"name\":\"Anthem Foundation Commits $13 Million to Substance Use Disorder Programs - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220525005134\\\/en\\\/1465880\\\/21\\\/AnthemFoundation_Logo.jpg\",\"datePublished\":\"2022-05-25T13:01:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220525005134\\\/en\\\/1465880\\\/21\\\/AnthemFoundation_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220525005134\\\/en\\\/1465880\\\/21\\\/AnthemFoundation_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anthem Foundation Commits $13 Million to Substance Use Disorder Programs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anthem Foundation Commits $13 Million to Substance Use Disorder Programs - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/","og_locale":"en_US","og_type":"article","og_title":"Anthem Foundation Commits $13 Million to Substance Use Disorder Programs - Pharma Trend","og_description":"The Foundation will invest up to $30 million over next three years to programs that support the mental health and well-being of communities with an emphasis on substance use disorders INDIANAPOLIS&#8211;(BUSINESS WIRE)&#8211;The Anthem Foundation, which will become Elevance Health Foundation on June 28, 2022, today announces the commitment of $13 million in grants to promote ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-25T13:01:40+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220525005134\/en\/1465880\/21\/AnthemFoundation_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Anthem Foundation Commits $13 Million to Substance Use Disorder Programs","datePublished":"2022-05-25T13:01:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/"},"wordCount":638,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220525005134\/en\/1465880\/21\/AnthemFoundation_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/","url":"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/","name":"Anthem Foundation Commits $13 Million to Substance Use Disorder Programs - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220525005134\/en\/1465880\/21\/AnthemFoundation_Logo.jpg","datePublished":"2022-05-25T13:01:40+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220525005134\/en\/1465880\/21\/AnthemFoundation_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220525005134\/en\/1465880\/21\/AnthemFoundation_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/anthem-foundation-commits-13-million-to-substance-use-disorder-programs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Anthem Foundation Commits $13 Million to Substance Use Disorder Programs"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44336"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44336\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}